PAXORLEA Trademark

Trademark Overview

On Tuesday, December 20, 2022, a trademark application was filed for PAXORLEA with the United States Patent and Trademark Office. The USPTO has given the PAXORLEA trademark a serial number of 97725615. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, January 19, 2024. This trademark is owned by Athenex, Inc.. The PAXORLEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and drugs for use in the treatment of cancer; Pharmaceutical preparations and drugs for use in chemotherapy; Pharmaceutical preparations and drugs for use in the field of oncology and immuno-oncology; Pharmaceutical preparations and drugs for use in the treatment of oncological diseases and disorders; Tumor suppressing pharmaceutical preparations and drugs; Pharmaceutical products for the prevention and treatment of cancer; Chemotherapeutic drugs; Components of pharmaceutical preparations; Pharmaceutical preparations sold as a component of a pharmaceutical product; Pharmaceutical compounds and substances sold as components of pharmaceutical products and preparations for the treatment of cancer; Active pharmaceutical ingredient being a component in pharmaceutical preparations for the treatment of cancer
paxorlea

General Information

Serial Number97725615
Word MarkPAXORLEA
Filing DateTuesday, December 20, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, January 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and drugs for use in the treatment of cancer; Pharmaceutical preparations and drugs for use in chemotherapy; Pharmaceutical preparations and drugs for use in the field of oncology and immuno-oncology; Pharmaceutical preparations and drugs for use in the treatment of oncological diseases and disorders; Tumor suppressing pharmaceutical preparations and drugs; Pharmaceutical products for the prevention and treatment of cancer; Chemotherapeutic drugs; Components of pharmaceutical preparations; Pharmaceutical preparations sold as a component of a pharmaceutical product; Pharmaceutical compounds and substances sold as components of pharmaceutical products and preparations for the treatment of cancer; Active pharmaceutical ingredient being a component in pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAthenex, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBuffalo, NY 14203

Trademark Events

Event DateEvent Description
Friday, January 19, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, January 19, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, January 19, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, September 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 21, 2023NON-FINAL ACTION E-MAILED
Thursday, September 21, 2023NON-FINAL ACTION WRITTEN
Wednesday, September 20, 2023ASSIGNED TO EXAMINER
Tuesday, January 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 23, 2022NEW APPLICATION ENTERED

Related Keywords

paxorlea pharmaceutical preparations drugs treatment cancer component sold products oncology components